In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease STAT Nawigacja wpisu Family members of those who donated their bodies to the Stanford School of Medicine join memorial service – Stanford Medical Center Report FDA approves two sickle cell therapies, including first CRISPR medicine – The Washington Post
